Leading integrated drug discovery, development and manufacturing organisation, Concept Life Sciences has carved out its Bradford analytical chemistry business to Cormica the specialists in testing services for medical device and pharmaceutical manufacturers. Both Concept Life Sciences and Cormica are part of private equity house, Limerston Capital LLP and sit as part of its healthcare portfolio...

Limerston Capital LLP (Limerston Capital) has announced the acquisition of Concept Life Sciences, a leading integrated drug discovery, development and manufacturing organisation, in a carve-out from Spectris plc. The deal will see Concept Life Sciences cement its position at the forefront of the pharmaceutical and life science sectors and provide it with a platform for further growth...

Concept Life Sciences (CLS), a Malvern Panalytical brand, has announced that it has received certification of compliance with Good Manufacturing Practice (GMP) for the production of active substances at its site in Sandwich, UK. This is the successful outcome of an in-depth Medicines and Healthcare products Regulatory Agency (MHRA) inspection and applies to active pharmaceutical ingredients (APIs) for both human and veterinary use...

Malvern Panalytical (Malvern, UK and Almelo, The Netherlands), manufacturer of analytical systems, and Concept Life Sciences (Cheshire, UK), a contract research organization, have today announced a full business integration. The integration will expand the existing analytical instrument and service relationship (Amplify Analytics) to include the Chemistry and Biology services of CLS. Both entities are operating businesses within the Spectris plc Group...

Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, has unveiled a new, state-of-the-art clinical and niche commercial facility to support pharmaceutical and biotechnology companies throughout the development and manufacture of active pharmaceutical ingredients (API)....

Concept Life Sciences has added polycyclic aromatic hydrocarbon (PAH) analysis in edible oils to its range of ISO 17025 accredited services.

PAHs have been linked to a number of health issues including various forms of cancer, therefore, the food and allied industries have a responsibility to ensure product safety. The recently accredited service meets the demands of the edible oils industry for both food and pharmaceutical use and complies....

Dr Andrew Clifton joins Concept Life Sciences as Head of Bioassay Development and Screening Technologies.

Dr Graeme Clark PHD has joined Concept Life Sciences Dundee as Director of Analytical Services and DMPK.

Concept Life Sciences offers tailored preclinical services in areas including investigative and mechanistic toxicology, exploratory and discovery toxicology, PK and metabolism and dermal absorption, as well as providing integrated drug discovery programs....

Concept Life Sciences has further expanded its analytical testing capabilities by making significant investment into Micro Chamber and Thermal Extraction facilities, used to sample VOCs or SVOCs emitted from products and materials.

UK-based drug discovery services provider Peakdale Molecular (part of the Concept Life Sciences Group) has strengthened its sales and marketing team through the addition of a Head of Sales and Marketing.

Gordon Woodrow, BSc in Applied Microbiology, has been appointed Head of Sales and Marketing and joins Peakdale with over 25 years of commercial experience having held a number of senior positions in companies offering scientific services to the pharmaceutical and biotech industries. Prior to joining Peakdale Gordon was responsible for business development and strategic alliances at Proteros Biostructures. Whilst there Gordon played...

Concept Life Sciences, scientific Laboratory and consultancy group has acquired pharmaceutical analytical testing business Agenda1 Analytical Services Ltd (Agenda 1).

This marks its fifth acquisition since it was formed in July 2014. Agenda 1 is a specialist contract analytical company delivering high quality analytical support to pharmaceutical, healthcare and medical device companies. Over the past year Concept Life Sciences has achieved an impressive organic growth rate and this deal is a prime example of how well-chosen partners can further expedite growth by extending capability. Agenda 1 was...

Concept Life Sciences, scientific Laboratory and consultancy group has acquired CXR Biosciences.

This marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life Sciences Group currently has over 600 staff in 11 core locations, with advanced plans for further expansion into continental Europe. CXR Biosciences is a leading investigative toxicology business. Its in-house expertise assists international life sciences companies to resolve issues relating to...

Concept Life Sciences, an international scientific laboratory and consultancy business, with a combined enterprise value approaching $100 million, has today announced the appointment of Matthew S. Jones as Chief Commercial Officer.

In this role, Mr Jones will be responsible for leading Concepts’ global commercial organisation, which encompasses all sales, business development, marketing activities, and strategic partnering efforts. A veteran of the life sciences industry with almost two decades of experience, Jones joins Concept Life Sciences having transformed, led and driven commercial growth strategies for a diverse range of life science businesses both in Europe and the...

Concept Life Sciences, a newly formed international scientific laboratory and consultancy business, has made three acquisitions with a combined enterprise value approaching $100 million.

The companies the group has acquired are Peakdale Molecular Limited, Resource & Environmental Consultants Limited and Scientific Analysis Laboratories Limited. Concept Life Sciences is led by Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan. Michael Fort has significant experience in the life sciences field having most recently held the position of Chief Executive Officer of Synexus Clinical Research where he worked for over 11 years. Michael has been involved in more than five M&A deals with a track record of building substantial value in the SME sector...